|Articles|March 27, 2015

PPD Migrates CTMS to Oracle Health Sciences Cloud

Author(s)Applied Clinical Trials Editorial Staff

PPD gains real-time and actionable insight into studies with simplified data exchange and monitoring through the cloud

PPD has migrated 124 studies from an onsite installation of Oracle’s Siebel Clinical Trial Management System to its cloud service. Using Siebel Clinical Trial Management System Cloud Service with a standardized clinical trial management system (CTMS) configuration, the data migration to the Oracle Health Sciences Cloud took six weeks.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

PPD Migrates CTMS to Oracle Health Sciences Cloud

Related Content

The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research

Breaking the Efficacy Ceiling in IBD and Beyond

ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

How to Tell Substance from Branding in Biotech's Support Ecosystem

Trending on Applied Clinical Trials Online

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

Breaking the Efficacy Ceiling in IBD and Beyond

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap